Effect of Twice-Yearly Denosumab on Prevention of Bone Mineral Density Loss inDe NovoKidney Transplant Recipients: A Randomized Controlled Trial-Reference-Cited by-同舟云学术

Effect of Twice-Yearly Denosumab on Prevention of Bone Mineral Density Loss inDe NovoKidney Transplant Recipients: A Randomized Controlled Trial

Author:

Bonani M.¹,Frey D.²,Brockmann J.³,Fehr T.¹,Mueller T. F.¹,Saleh L.⁴,von Eckardstein A.⁴,Graf N.⁵,Wüthrich R. P.¹

Affiliation:

1. Division of Nephrology; University Hospital Zürich and University of Zürich; Zürich Switzerland

2. Division of Rheumatology; University Hospital Zürich and University of Zürich; Zürich Switzerland

3. Division of Visceral and Transplantation Surgery; University Hospital Zürich and University of Zürich; Zürich Switzerland

4. Institute of Clinical Chemistry; University Hospital Zürich and University of Zürich; Zürich Switzerland

5. Graf Biostatistics; Winterthur Switzerland

Funder

University Hospital Zürich

Universität Zürich

Publisher

Wiley

Subject

Pharmacology (medical),Transplantation,Immunology and Allergy

Reference33 articles.

4. Posttransplantation bone disease;Cunningham;Transplantation,2005

Cited by 81 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献